Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.63 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.63 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | BACE1 | P56817 | 3/20 | 0.46 |
| ▸ | CTSD | P07339 | 2/20 | 0.46 |
| ▸ | ACE | P12821 | 2/20 | 0.42 |
| ▸ | MME | P08473 | 2/20 | 0.42 |
| ▸ | CPA1 | P15085 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | GRM8 | O00222 | 1/20 | 0.39 |
| ▸ | GRM6 | O15303 | 1/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL751144 | 1.00 | DPP4 (0.63) | DPP4DPP8DPP9ALOX15BLM | |
| Hydrochloric Acid SCHEMBL23404089 | 0.98 | DPP4 (0.61) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL29499873 | 0.97 | DPP4 (0.59) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL29630514 | 0.92 | DPP4 (0.55) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL30193486 | 0.89 | DPP4 (0.52) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL31571449 | 0.89 | BACE1 (0.58) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL29777801 | 0.89 | DPP4 (0.52) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL8070748 | 0.88 | DPP4 (0.51) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL31031607 | 0.88 | BACE1 (0.54) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL29478400 | 0.88 | BACE1 (0.54) | DPP4DPP8DPP9ALOX15BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11534475-B2 | Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue | ZYTOPROTEC GMBH (AT) | 2022-12-27 | — | — | US | claimed |
| US-20200113965-A1 | CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE | ZYTOPROTEC GMBH (AT) | 2020-04-16 | — | — | US | claimed |
| US-20180177838-A1 | CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE | ZYTOPROTEC GMBH (AT) | 2018-06-28 | — | — | US | claimed |
| US-9931369-B2 | Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue | ZYTOPROTEC GMBH (AT) | 2018-04-03 | — | — | US | claimed |
| US-20140142051-A1 | CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE | ZYTOPROTEC GMBH (AT) | 2014-05-22 | — | — | US | claimed |
| EP-2129370-B1 | Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue | ZYTOPROTEC GMBH (AT) | 2012-11-21 | — | — | EP | claimed |
| US-20100099628-A1 | CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE | ZYTO-PROTEC GMBH (AT) | 2010-04-22 | — | — | US | claimed |
| EP-2129370-A1 | CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE | Zytoprotec Gmbh (AT) | 2009-12-09 | — | — | EP | claimed |
| WO-2008106702-A1 | CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE | ZYTOPROTEC GMBH (AT) | 2008-09-12 | — | — | WO | claimed |
| EP-0457314-A1 | Nutrient compositions containing peptides | CLINTEC NUTRITION COMPANY (US) | 1991-11-21 | — | — | EP | claimed |
| US-11534475-B2 | Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue | ZYTOPROTEC GMBH (AT) | 2022-12-27 | — | — | US | disclosed |
| US-11534475-B2 | Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue | ZYTOPROTEC GMBH (AT) | 2022-12-27 | — | — | US | disclosed |
| US-20200113965-A1 | CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE | ZYTOPROTEC GMBH (AT) | 2020-04-16 | — | — | US | disclosed |
| US-20200113965-A1 | CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE | ZYTOPROTEC GMBH (AT) | 2020-04-16 | — | — | US | disclosed |
| EP-2797596-B1 | PERITONEAL DIALYSIS FLUID COMPRISING A GSK-3 INHIBITOR | ZYTOPROTEC GMBH (AT) | 2019-06-26 | — | — | EP | disclosed |
| EP-2035047-A2 | EXTRACELLULAR MATRIX COMPOSITION | Restoration Of Appearance & Function Trust (GB) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008106702-A1 | CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE | ZYTOPROTEC GMBH (AT) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008106702-A1 | CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE | ZYTOPROTEC GMBH (AT) | 2008-09-12 | — | — | WO | disclosed |
| WO-2007144644-A2 | EXTRACELLULAR MATRIX COMPOSITION | RESTORATION OF APPEARANCE & FUNCTION TRUST (GB) | 2007-12-21 | — | — | WO | disclosed |
| US-20060217321-A1 | Compositions to improve tic disorders | TAIYOKAGAKU CO., LTD. (JP) | 2006-09-28 | — | — | US | disclosed |